The global pharmaceutical processing seals market size is expected to reach USD 4.92 billion by 2030, according to a new study by Polaris Market Research. The report “Pharmaceutical Processing Seals Market Share, Size, Trends, Industry Analysis Report, By Type (O-rings, Gaskets, Lip seals, D seals, and Others); By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, FKM, FFKM, UHMWPE, and PU); By Application (Manufacturing Equipment, R&D, Quality Control, Packaging Equipment, Others); By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future industry growth.
The requirement for pharmaceutical processing seals is quite high due to the increased demand for cleanliness and sanitation. There is always be a need to enforce tight legal rules and purity requirements. Seals come into direct touch with a range of media at varying pressures and temperatures, so they must be fully free of side effects, dangers, and hazards. Not only should they always prevent process alterations or product contamination, but they should also avoid interfering with any active agents through interactions or component transfer.
Furthermore, the rising demand for new and innovative products, and rising demand from emerging nations, are projected to help fuel industry expansion. For instance, in December 2021, BDR Pharma, one of India’s major generic pharma businesses, has introduced Midostaurin, India’s first generic, under the brand name MSTARIN, which is used to treat rare and difficult-to-treat tumors. For adult women with newly diagnosed Acute Myeloid Leukemia (AML) who have mutated FLT3 gene, the drug is authorized in conjunction with standard care of both Daunorubicin and Cytarabine combination therapy coupled with chemotherapy sessions.
Based on the material, the silicon segment accounted for the leading share in the market, in 2021. Pharmaceutical processing covers are predicted to be in high demand due to capacity growth and ongoing innovation in the pharmaceutical sector. Silicone is used in the pharma sector because of its advantages, such as adaptability and resilience under extreme pressure and temperature, chemical resistance, and low bacterial growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-processing-seals-market/request-for-sample
Market players such as Trelleborg AB, Freudenberg Group, IDEX Corporation, Parker Hannifin Corporation, John Crane, Morgan Advanced Materials Plc, Saint-Gobain S.A., Flowserve Corporation, James Walker, are some key players operating in the global market.
In September 2021, Parker Hannifin, a leader in motion and control technologies, announced the acquisition of all of Meggitt Plc’s shares. Thus, the major players are working to enhance the market with their agreement by investing in the pharmaceutical processing seals products to boost market growth during the forecast period.
Polaris Market Research has segmented the pharmaceutical processing seals market report based on type, material, application, and region:
Pharmaceutical Processing Seals, Material Outlook (Revenue – USD Billion, 2017 – 2030)
- Nitrile Rubber
Pharmaceutical Processing Seals, Type Outlook (Revenue – USD Billion, 2017 – 2030)
- Lip seals
- D seals
Pharmaceutical Processing Seals, Application Outlook (Revenue – USD Billion, 2017 – 2030)
- Manufacturing equipment
- Quality control
- Packaging equipment
Pharmaceutical Processing Seals, Regional Outlook (Revenue – USD Billion, 2017 – 2030)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa